β2-Adrenergic agonist salbutamol augments hypertrophy in MHCIIa fibers and sprint mean power output but not muscle force during 11 weeks of resistance training in young men
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
β2-Adrenergic agonist salbutamol augments hypertrophy in MHCIIa fibers and sprint mean power output but not muscle force during 11 weeks of resistance training in young men. / Jessen, Søren; Reitelseder, Søren; Kalsen, Anders; Kreiberg, Michael; Onslev, Johan; Gad, Anders; Ørtenblad, Niels; Backer, Vibeke; Holm, Lars; Bangsbo, Jens; Hostrup, Morten.
I: Journal of Applied Physiology, Bind 130, Nr. 3, 2021, s. 617-626.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - β2-Adrenergic agonist salbutamol augments hypertrophy in MHCIIa fibers and sprint mean power output but not muscle force during 11 weeks of resistance training in young men
AU - Jessen, Søren
AU - Reitelseder, Søren
AU - Kalsen, Anders
AU - Kreiberg, Michael
AU - Onslev, Johan
AU - Gad, Anders
AU - Ørtenblad, Niels
AU - Backer, Vibeke
AU - Holm, Lars
AU - Bangsbo, Jens
AU - Hostrup, Morten
N1 - CURIS 2021 NEXS 099
PY - 2021
Y1 - 2021
N2 - In this study, we examined the effect of β2-agonist salbutamol at oral doses during a period of resistance training on sprint performance, quadriceps contractile function, skeletal muscle hypertrophy, fiber type composition, maximal activity of enzymes of importance for anaerobic energy turnover, and sarcoplasmic reticulum Ca2+ handling in young men. Twenty-six men (23 ± 2 yr; means ± SD) were randomized to daily intake of oral salbutamol (16 mg/day; RES+SAL) or placebo (RES) during 11 wk of full-body resistance training 3 times/wk. Mean power output during 10-s maximal cycling increased more (P = 0.027) in RES+SAL (+ 12%) than in RES ( þ 7%), whereas peak power output increased similarly (RES+SAL: + 8%; RES: + 7%; P = 0.400). Quadriceps dynamic peak torque and maximal voluntary isometric torque increased by 13 and 14% (P ≤ 0.001) in RES+SAL and 13 and 13% (P ≤ 0.001) in RES, respectively. Myosin heavy-chain (MHC) isoform distribution transitioned from MHCI and MHCIIx toward MHCIIa in RES+SAL (P = 0.002), but not in RES (P = 0.323). MHCIIa cross-sectional-area increased more (P = 0.040) in RES+SAL (+ 35%) than RES (+ 21%). Sarcoplasmic reticulum Ca2+ release rate increased in both groups (RES+SAL: + 9%, P = 0.048; RES: + 13%, P = 0.008), whereas Ca2+-uptake rate increased only in RES (+ 12%, P = 0.022) but was not different from the non-significant change in RES+SAL (+ 2%, P = 0.484). Maximal activity of lactate dehydrogenase increased only in RES+SAL (+ 13%, P = 0.008). Muscle content of the dihydropyridine receptor, ryanodine receptor 1, and sarcoplasmic reticulum Ca2+-ATPase iso-form 1 and 2 did not change with the intervention in either group (P ≥ 0.100). These observations indicate that the enhancement of sprint mean power output induced by salbutamol is at least partly attributed to greater hypertrophy of MHCIIa fibers and transition toward the MHCIIa isoform.
AB - In this study, we examined the effect of β2-agonist salbutamol at oral doses during a period of resistance training on sprint performance, quadriceps contractile function, skeletal muscle hypertrophy, fiber type composition, maximal activity of enzymes of importance for anaerobic energy turnover, and sarcoplasmic reticulum Ca2+ handling in young men. Twenty-six men (23 ± 2 yr; means ± SD) were randomized to daily intake of oral salbutamol (16 mg/day; RES+SAL) or placebo (RES) during 11 wk of full-body resistance training 3 times/wk. Mean power output during 10-s maximal cycling increased more (P = 0.027) in RES+SAL (+ 12%) than in RES ( þ 7%), whereas peak power output increased similarly (RES+SAL: + 8%; RES: + 7%; P = 0.400). Quadriceps dynamic peak torque and maximal voluntary isometric torque increased by 13 and 14% (P ≤ 0.001) in RES+SAL and 13 and 13% (P ≤ 0.001) in RES, respectively. Myosin heavy-chain (MHC) isoform distribution transitioned from MHCI and MHCIIx toward MHCIIa in RES+SAL (P = 0.002), but not in RES (P = 0.323). MHCIIa cross-sectional-area increased more (P = 0.040) in RES+SAL (+ 35%) than RES (+ 21%). Sarcoplasmic reticulum Ca2+ release rate increased in both groups (RES+SAL: + 9%, P = 0.048; RES: + 13%, P = 0.008), whereas Ca2+-uptake rate increased only in RES (+ 12%, P = 0.022) but was not different from the non-significant change in RES+SAL (+ 2%, P = 0.484). Maximal activity of lactate dehydrogenase increased only in RES+SAL (+ 13%, P = 0.008). Muscle content of the dihydropyridine receptor, ryanodine receptor 1, and sarcoplasmic reticulum Ca2+-ATPase iso-form 1 and 2 did not change with the intervention in either group (P ≥ 0.100). These observations indicate that the enhancement of sprint mean power output induced by salbutamol is at least partly attributed to greater hypertrophy of MHCIIa fibers and transition toward the MHCIIa isoform.
KW - Faculty of Science
KW - Adrenoceptors
KW - Athletes
KW - Kin-com
KW - Dynamometer
KW - Doping
U2 - 10.1152/japplphysiol.00553.2020
DO - 10.1152/japplphysiol.00553.2020
M3 - Journal article
C2 - 33357007
VL - 130
SP - 617
EP - 626
JO - Journal of Applied Physiology
JF - Journal of Applied Physiology
SN - 8750-7587
IS - 3
ER -
ID: 254471547